Source: Annual Congress 2006 - Markers of inflammation in paediatric asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. F. Su, K. Yoon, A. Levy, D. Miller, P. Matz, M. Welch, D. Collins, R. Mehta, A. Cahn, R. Kunka (Philadelphia, Long Beach, Spartanburg, Dartmouth, Medford, San Diego, Research Triangle Park, United States Of America; Greenford, United Kingdom). Urine cortisol excretion in children 4–11 years old is not affected by therapeutic doses of fluticasone propionate HFA. Eur Respir J 2006; 28: Suppl. 50, 1512

Member's Comments

No comment yet.

Related content which might interest you: Low dose inhaled fluticasone propionate compared with montelukast in children 6-12 years old Source: Eur Respir J 2003; 22: Suppl. 45, 535s Year: 2003 Effect of ciclesonide and fluticasone propionate on lower leg growth rate and cortisol excretion in prepubertal children with mild asthma in a placebo-controlled study Source: Eur Respir J 2007; 30: Suppl. 51, 457s Year: 2007 Efficacy of fluticasone propionate in infants younger than two years with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005 Safety of Inhaled fluticasone propionate in children 2-4 years old Source: Eur Respir J 2003; 22: Suppl. 45, 133s Year: 2003 Is low dose inhaled fluticasone propionate safe in young children with asthma? Source: Annual Congress 2008 - Preschool wheezing: advances in diagnosis, phenotyping and therapy Year: 2008 Efficiency of fluticasone propinate with salmeterol in asthmatic children during 1 years Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Growth in asthmatic children treated with fluticasone propionate Source: Eur Respir J 2002; 20: Suppl. 38, 218s Year: 2002 Ciclesonide and fluticasone propionate show comparable efficacy in children and adolescents with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004 Effects of ciclesonide on lung function and cortisol excretion in adolescent asthma patients – a comparative study with budesonide Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006 Evaluation of long-term safety, growth and efficacy of fluticasone propionate 100mcg bd compared with sodium cromoglycate 5mg qds in asthmatic children aged 12-47 months Source: Eur Respir J 2002; 20: Suppl. 38, 219s Year: 2002 Safety profile of ciclesonide as compared with fluticasone propionate in the treatment of children and adolescents with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004 High doses of inhaled fluticasone propionate dose-dependently suppress adrenal cortical function in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 290s Year: 2001 Efficacy of salmeterol/fluticasone propionate MDI versus higher dose fluticasone propionate in adolescent and adult asthmatics uncontrolled on fluticasone propionate alone Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003 Prevalence of subnormal adrenal responses to low dose synthetic ACTH (synacthen) in children receiving ≥ 500 mcg daily of the inhaled steroid fluticasone propionate (FP) Source: Eur Respir J 2003; 22: Suppl. 45, 310s Year: 2003 Effects on adrenal function of a new combination of fluticasone propionate/formoterol fumarate administered to asthmatic patients and healthy subjects Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma Source: Eur Respir J 2004; 23: 354-355 Year: 2004 Fluticasone propionate in asthmatic children: a long term dose comparison of safety and efficacy Source: Eur Respir J 2001; 18: Suppl. 33, 288s Year: 2001 Effect of inhaled corticosteroid fluticasone propionate on linear growth in preschool children with asthma Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Salmeterol/fluticasone propionate combination (SFC) versus doubling dose of fluticasone propionate (FP) in children with asthma insufficiently controlled on moderate doses of inhaled corticosteroids Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Serum and urine eosinophil markers in children and adolescents with asthma treated with once or twice daily inhaled glucocorticoids Source: Eur Respir J 2001; 18: Suppl. 33, 449s Year: 2001